In Review: Since cross-over, PCMA has been working in the Senate to amend HB 1363, which would require the State Health Benefit Plant to study the cost implications of moving to a NADA + reimbursement methodology for pharmacy reimbursement. PCMA is focused on removing “trigger” language in the bill that would force the SHBP to adopt the NADAC + methodology.
Up Next: PCMA and our members will continue to educate Senators on HB 1363 and HB 924, which is the ban on white bagging legislation.
If you have any questions, please contact Michael Power at mpower@pcmanet.org.
